Bio-Techne Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
I'm PortAI, I can summarize articles.
Bio-Techne Corp.'s stock rose 1.18% to $58.96 on Monday, marking its third consecutive day of gains. Despite this, it underperformed compared to competitors like Amgen Inc. and Charles River Laboratories, which saw higher gains. Bio-Techne remains 25.63% below its 52-week high of $79.28. The S&P 500 and Dow Jones also saw gains on the same day.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments